S. Durviaux

发表

Hepatocyte nuclear factor 6, a transcription factor that contains a novel type of homeodomain and a single cut domain.

J. Hsuan, G. Rousseau, F. Lemaigre, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial

D. Vaughn, Ping Li, L. Fries, 2014, The Journal of infectious diseases.

Transcription Factor Hepatocyte Nuclear Factor 6 Regulates Pancreatic Endocrine Cell Differentiation and Controls Expression of the Proendocrine Gene ngn3

P. Carmeliet, O. Madsen, F. Guillemot, 2000, Molecular and Cellular Biology.

Genetic and Antigenic Typing of Seasonal Influenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efficacy Trial

A. Nowakowski, J. Treanor, G. Feldman, 2013, Clinical and Vaccine Immunology.

Hepatocyte nuclear factor-6: associations between genetic variability and Type II diabetes and between genetic variability and estimates of insulin secretion

A. M. Møller, T. Hansen, O. Pedersen, 1999, Diabetologia.

Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial.

T. Vesikari, S. Durviaux, J. Devaster, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Liver-specific factor binding to the liver promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.

G. Rousseau, F. Lemaigre, S. Durviaux, 1993, The Journal of biological chemistry.

A new method for the physical and genetic mapping of large plasmids: application to the localisation of the virulence determinants on the 90 kb plasmid of Salmonella typhimurium.

G. Cornelis, T. Michiels, S. Durviaux, 1987, Microbial pathogenesis.

Relative Ef ﬁ cacy of AS03-Adjuvanted Pandemic In ﬂ uenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Ef ﬁ cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Relative Ef fi cacy of AS 03-Adjuvanted Pandemic In fl uenza A ( H 1 N 1 ) Vaccine in Children : Results of a Controlled , Randomized Ef fi cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Identification of regulatory sequences and protein-binding sites in the liver-type promoter of a gene encoding 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase

G. Rousseau, F. Lemaigre, S. Durviaux, 1991, Molecular and cellular biology.

SplCanDisplace GHF-1fromItsDistal Binding SiteandStimulate Transcription fromtheGrowthHormoneGenePromoter

S. Durviaux, 1990 .

Genetic and Antigenic Typing of Seasonal Inﬂuenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efﬁcacy Trial

A. Nowakowski, G. Leroux-Roels, G. Ruiz-Palacios, 2014 .

Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

A. Falsey, A. Nowakowski, Shinn-Jang Hwang, 2014, The Journal of infectious diseases.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2016, Journal of Infection.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK

Dave Singh, U. Kolsum, S. Durviaux, 2017, International journal of chronic obstructive pulmonary disease.

Vaccine for prevention of mild and moderate-to-severe influenza in children.

O. Ofori-Anyinam, G. Dbaibo, B. Quiambao, 2013, The New England journal of medicine.